SCHEMBL13853508

SCHEMBL13853508

CNC(=O)N[C@H](C)c1cccc(OC)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.64
POLB P06746 2/20 0.61
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
LMNA P02545 1/20 0.60
HTT P42858 1/20 0.60
ROCK1 Q13464 10/20 0.56
ROCK2 O75116 8/20 0.56
PRKG1 Q13976 3/20 0.56
PRKACA P17612 3/20 0.56
GSK3A P49840 3/20 0.56
GSK3B P49841 3/20 0.56
PRKX P51817 3/20 0.56
PRKCQ Q04759 3/20 0.56
CYP3A4 P08684 2/20 0.56
CHEK1 O14757 2/20 0.56
CLK4 Q9HAZ1 2/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
RPS6KA5 O75582 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13853510 1.00 SMN1; SMN2 (0.64) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL8178559 0.87 POLB (0.64) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL14380839 0.84 ACACB (0.67) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL28360621 0.84 POLB (0.64) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL6969020 0.84 ACACB (0.67) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL25274189 0.83 POLB (0.63) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL31173723 0.83 POLB (0.63) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL15831237 0.83 POLB (0.63) SMN1; SMN2POLBMEN1KMT2ALMNA
SCHEMBL17335712 0.81 MEN1 (0.67) SMN1; SMN2POLBMEN1KMT2AROCK1
SCHEMBL18722726 0.81 MEN1 (0.67) SMN1; SMN2POLBMEN1KMT2AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354418-B2 Thiazolyl-dihydro-quinazolines BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-15 US disclosed
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-21 US disclosed
US-20070238746-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238746-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 SMN1; SMN2 3842/4885POLB 3678/4885MEN1 2880/4885
US-20090131424-A1 THIAZOLYL-DIHYDRO-CHINAZOLINE CYP3A7, UGT2B7, UGT1A7 SMN1; SMN2 3842/4885POLB 3678/4885MEN1 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.